ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Gore, Agency Report, Support Legislation To Protect Genetic Info

January 30, 1998

HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report

July 10, 1998

More Patients Get Screened, Colorectal Death Rates Drop

July 29, 2011

CMS Proposes To End Automatic Coverage Of Clinical Trials For Medicare Patients.

October 12, 2007

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

Who Will Determine Pay Lines For Each Program at NCI? Upton Suggests A Collective Approach

February 17, 1978